Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Receivables - Other (2016 - 2023)

Fortress Biotech (FBIO) has 10 years of Receivables - Other data on record, last reported at $100000.0 in Q4 2023.

  • For Q4 2023, Receivables - Other fell 94.74% year-over-year to $100000.0; the TTM value through Dec 2023 reached $100000.0, down 94.74%, while the annual FY2023 figure was $100000.0, 94.74% down from the prior year.
  • Receivables - Other reached $100000.0 in Q4 2023 per FBIO's latest filing, down from $300000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $1.9 million in Q4 2022 and bottomed at $29000.0 in Q1 2020.
  • Average Receivables - Other over 5 years is $411285.7, with a median of $400000.0 recorded in 2019.
  • Peak YoY movement for Receivables - Other: soared 3900.0% in 2019, then tumbled 94.74% in 2023.
  • A 5-year view of Receivables - Other shows it stood at $200000.0 in 2019, then soared by 200.0% to $600000.0 in 2020, then plummeted by 33.33% to $400000.0 in 2021, then soared by 375.0% to $1.9 million in 2022, then crashed by 94.74% to $100000.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Receivables - Other were $100000.0 in Q4 2023, $300000.0 in Q1 2023, and $1.9 million in Q4 2022.